Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using Illumina's next-generation sequencing (NGS) platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data derived from VUMC's extensive, high-quality biobank of approximately 250,000 de-identified human DNA samples and associated longitudinal, structured medical data.
One Year Under President Biden: What's Changed for EHS&S?
It’s been a busy year for the Biden administration and there’s been a lot of progress on his environmental policy since the start of his term. Let’s run through the most significant EHS&S initiatives of his first year and what lies ahead.
Subscribe to